Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Woodcock ‘Managing As If She’s Been Commissioner,’ Not Afraid To Act, CBER Director Says
Oct 13 2021
•
By
Derrick Gingery
CBER Director Peter Marks says that Janet Woodcock is not acting like an acting commissioner. • Source: Nielsen Hobbs; the Pink Sheet | Getty, Alamy images
More from US FDA
More from Agency Leadership